demonstrated that exosomal HSPC111 from colorectal cancer (CRC) cells promoted the formation of pre-metastatic niches and liver metastasis by altering lipid metabolism in CAFs, suggesting that HSPC111 may represent a potential therapeutic target (96). This evidence concerns the gene NOP16 and colorectal cancer.